FERC accepted the New York Independent System Operator, Inc.’s (“NYISO”) proposed revisions to its Market Administration ...

Doing it yourself can be cheaper, faster and more profitable than traditional publishing, but the writers do all the work.

UPDATE: Real Women Have Curves: The Musical has announced additional members of the production’s Broadway company who will join the previously announced Tatianna Córdoba (Ana) and Justina ...

Employers’ plans aren’t so different. And for the first time in over a year, salesperson is no longer the single most in-demand job overall — though to be fair, it only fell to second place.

And if the weather and animal disease allows, we should see good milk production growth moving forward.” But would demand be strong enough to absorb the growing global supply without pushing prices ...

US drivers could get some relief at the pump in the next two years as oil supply surpasses global demand, according to the US Energy Information Administration. The agency said US gasoline prices ...

OPEC has reiterated its earlier forecast that global oil demand will expand at a robust clip at 1.4 mb/d in 2025, largely driven by strong non-OECD (Organization for Economic Co-operation and ...

Data centers are expected to continue growing at a breakneck pace, doubling their power demand by 2029, according to a new report from JLL. The industry’s expansion, fueled by the rapid growth ...

HOUSTON (Reuters) -Oil prices slipped on Tuesday after a U.S. government agency forecast steady U.S. oil demand in 2025 while lifting its forecast for supply. Declines were limited by new U.S ...

Homebuyer demand for mortgages is now at the lowest level in 30 years, according to data from the real estate analytics tool Reventure App. Newsweek contacted the Mortgage Bankers Association for ...

NEW YORK (Reuters) - Investors are souring on the U.S. oil refining sector, citing forecasts for softer fuel demand and worries ... the back of a weaker forward curve," Jefferies analysts said ...

Demand for its COVID vaccine has been waning since the pandemic, while adoption of its RSV shot - its second approved product- has been slower than expected, forcing Moderna to cut costs.